Crinetics Pharma - CRNX Quarterly EPS earnings growth

Crinetics Corp - graphic logo of issuer CRNX

Crinetics Pharmaceuticals (CRNX) is currently utilizing its accumulated reserves while awaiting the launch of its products. The current quarterly EPS pace reflects profit dynamics, where the value 7.00 represents the current figure. The business relies on a global network of laboratories for component synthesis, while its competitive advantage is driven by convenient oral treatment forms for rare endocrine pathologies instead of injections.

Crinetics (CRNX) - Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 09/12/2026

Financial and market metric breakdowns for Crinetics Pharmaceuticals (CRNX)

- share price and consensus valuation forecast:
Analysis of all company metrics:Crinetics Pharmaceuticals
Manufactured product of Crinetics Corp

The assessment of business operational efficiency is based on profit generation dynamics. This indicator measures the daily rate of change in earnings per share, revealing the actual speed of capital growth. For Crinetics Pharmaceuticals (CRNX), this trend reflects the impact of chemical synthesis optimization and cost reductions on production sustainability. By analyzing the quarterly growth in earnings per share, an investor determines whether the stock's valuation is overheated.

Competitors of Crinetics Pharmaceuticals (CRNX)

ASND (Ascendis Pharma) - Year-over-year net earnings per share growth for the last 12 months|MDGL: Year-over-year earnings per share growth rate for the last twelve months|CORT (Corcept Therapeutics Corp) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Rhythm Pharmaceuticals|Quarterly EPS earnings growth AKRO|Year-over-year earnings per share growth for the last twelve months MTSR (Metsera, Inc.)|Year-over-year earnings per share growth for the last twelve months moonlaketx.com MLTX|NewAmsterdam Pharma Corp (NAMS) - Earnings per share growth in annualized terms for the last twelve months|SLNO - Year-over-year earnings per share growth for the last twelve months|FOLD: Year-over-year earnings per share growth for the last twelve months|ETNB: Quarterly EPS earnings growth|AGIO - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Structure Corp|MiMedx Corp (MDXG) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months rezolutebio.com (RZLT)|Year-over-year net earnings per share growth for the last 12 months lexpharma.com LXRX|Quarterly EPS earnings growth MBX (MBX Biosciences)|Altimmune Corp - Year-over-year earnings per share growth for the last twelve months|Aardvark Therapeutics Inc. - Quarterly EPS earnings growth|SGMT - Quarterly EPS earnings growth|BioAge Labs (BIOA) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months biomeafusion.com (BMEA)|Year-over-year earnings per share growth for the last twelve months Quince Therapeutics, Inc.|Year-over-year net earnings per share growth for the last 12 months Fractyl (GUTS)|Year-over-year net earnings per share growth for the last 12 months VTVT (vTv Therapeutics Inc.)|ATPC - Earnings per share growth in annualized terms for the last twelve months|Pluri Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Synlogic Corp|LPCN - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Matinas BioPharma Holdings, Inc. MTNB|SPRB: Quarterly EPS earnings growth|Galecto Corp - Year-over-year earnings per one share growth for the last 12 months|CTCX (carmellrx.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth lumos-pharma.com|Quarterly EPS earnings growth ONVO|Year-over-year net earnings per share growth for the last 12 months Radius Health RDUS